Alliance formed to cure glioblastoma with personalized medicine
A new-generation clinical trial for glioblastoma multiforme (GBM) — the deadliest form of brain cancer – will begin enrolling patients...
CLL survival greatly improved by ibrutinib
A multi-center, international, randomized, Phase III study of older untreated patients with chronic lymphocytic leukemia (CLL)...
Why some drugs don’t work against pancreatic cancer
An MD Anderson study may explain why chemotherapy drugs such as gemcitabine are ineffective against pancreatic cancer in some...
This gene could unlock an immune attack on cancer
A team led by researchers at MD Anderson Cancer Center reports a crucial tumor-thwarting gene protects an immune attack against lung...
Innovations in the OR
A cadre of elite surgeons is making a mark as pioneering researchers at MD Anderson. In the operating room, they’re not just excising...
Some colorectal cancers recur after treatment. But why?
Cetuximab, marketed as Erbitux®å, is one of the key therapies for metastatic colorectal cancer. Yet the cancer still returns in some...
How you cook meat could cause cancer
Diets high in meats cooked by high-temperature techniques such as barbecuing and pan-frying, which produce carcinogenic compounds, may...
Big collaboration based on nano-sized particles
Leveraging recent advances in the biology of extracellular vesicles and their role in intercellular communication, Codiak BioSciences,...
CPRIT grants continue to fuel the cancer fight
MD Anderson Cancer Center was awarded more than $22 million in research grants in November from the Cancer Prevention and Research...
Two faculty members named AAAS Fellows
Distinguished contributions to understanding p53 tumor suppression in stem cells and breakthrough advances in treating breast cancer...
Why are HPV vaccination rates so low?
National leaders and cancer center representatives recently met in Houston to review strategies for improving human papillomavirus...
A simple answer for patients with Lynch syndrome
People with Lynch syndrome face a high risk of colorectal cancer. But researchers think that reducing this risk may be as easy as...
Is the common cold the cure for cancer?
Glioblastomas, or malignant gliomas, are sometimes called “grow-and-go” tumors. They make their own blood supply, which fuels the...
Why a protein causes tumor growth in brain, but not other...
It’s no surprise that people enjoy warm places like Hawaii, but may suffer in hostile locales such as Antarctica. A tumor suppressor...
Experts' goal? Tweak skin cancer prevention game plan
Cancer prevention experts throughout the nation discussed new strategies for preventing skin cancer at the Texas Skin Cancer/Melanoma...
A better therapy for lung cancer
An analysis of an international, cooperative-led trial of patients with locally advanced non-small cell lung cancer (NSCLC) has shown...
The reasons why an anemia drug is hurting some patients
Scientists have shown why a drug widely used to treat chemotherapy-induced anemia in ovarian and breast cancer patients also may...
Partnership yields new immunotherapy drug and a clinical...
A new drug that’s based on MD Anderson research and designed to rev up an immune system assault on cancer has advanced to clinical...
Expanding the moon shots mission
MD Anderson’s Moon Shots Program has expanded its targets, adding some of the most intractable cancers to its campaign to more rapidly...
CVS's tobacco sales removal is proving effective
It’s been a year since CVS Pharmacy, the nation’s second largest chain of drugstores, stopped selling tobacco, and the company claims...
Immunotherapy drug extends survival for kidney cancer...
For the first time, a new drug from the field of immuno-oncology has proven to extend survival for patients with advanced kidney...
Vaccine helps T cells target tumors
A vaccine that delivers an antigen to dendritic cells, in turn activating killer T cells that can target specific cancers, is being...
Old surgical guidelines getting a fresh look
Patients who undergo surgery are recovering faster and getting discharged sooner thanks to MD Anderson’s enhanced surgical recovery...
A prescription for hope
Rafael Pantoja had all but lost hope.
The thyroid cancer he had battled for 14 years was back and spreading.
Then, earlier this...
Drug may become new standard of care for lung, GI NETs
A drug for pancreatic cancer that is also used to prevent rejection of organ transplants has been shown to delay progression of...
MD Anderson’s Allison wins American Cancer Society medal of...
A career-long fascination with discovering the ins and outs of T cells, our immune system’s tailor-made destroyers of infections and...
MD Anderson, Immatics partner to develop adoptive cellular...
Immatics Biotechnologies GmbH (Immatics) and MD Anderson have announced the launch of Immatics US, Inc., a new company aiming at...
Study reveals insight into DNA repair
DNA double-strand breaks (DSBs) are the worst possible form of genetic malfunction that can cause cancer and resistance to therapy....
New partnership to test immuno-oncology on solid tumors
Merck and MD Anderson have announced a strategic clinical research collaboration to evaluate Merck’s anti-PD-1 therapy, KEYTRUDA®å...
This generic heart medication may improve survival
In a first-of-its-kind study, researchers at MD Anderson Cancer Center have demonstrated a benefit in overall survival among...
Biomarker signals poor survival for colorectal cancer...
An MD Anderson study has found that a protein called CSN6 is linked to poor survival among patients with colorectal cancer.
The...
Former four-star admiral tapped as moon shots leader
MD Anderson has appointed former U.S. Public Health Service four-star Admiral Joxel Garcia, M.D. as the inaugural executive director...
Exploring tumor ‘microenvironment’ for alternate treatment...
Scientists know that activation of growth factor receptors such as epidermal growth factor receptors (EGFR) promote tumor progression...
Immunotherapy trailblazer Jim Allison wins Lasker Award
For his groundbreaking work in immunotherapy, Jim Allison, Ph.D., chair of Immunology at MD Anderson Cancer Center, will receive the...
A quest to detect lung cancer — before it’s too late
Early in his career, Sam Hanash, M.D., Ph.D., faced the difficult task of telling the families and loved ones of late-stage cancer...
MD Anderson named the top cancer hospital
MD Anderson has been ranked the No. 1 hospital for cancer care in the nation by U.S. News & World Report’s “Best Hospitals” survey.
Can this protein prevent or kill breast cancer tumors?
Every parent knows the maxim “feed a cold, starve a fever.” In cancer, however, exactly how to feed or starve a tumor has not been...
Similarities between embryos and breast tumors identified
Breast tumors may have something in common with embryos … at least in mice, say researchers at MD Anderson Cancer Center.
A study...
MD Anderson will be site of Genome Characterization Center
MD Anderson Cancer Center has been named a site for one of two new Genome Characterization Centers (GCC) funded through the National...
Turning the immune system against metastatic breast cancer
Although the cure rate for breast cancer has risen steadily in recent decades, recurrent or metastatic disease remains difficult to...
Many colorectal cancer cases among certain group are...
Hereditary colorectal cancers, caused by inherited gene mutations, are relatively rare for most patients. However, researchers at MD...
Reducing risk while leaving menopause for later
Women with BRCA1 mutations have a 39% risk of ovarian cancer compared to the general population’s risk of 1.3%, while women with BRCA2...
Mutated gene may boost cancer drugs’ effectiveness
Mutations in the ARID1a gene, which are common in many cancer types, disrupt DNA damage repair in cancer cells, allowing the cancer to...
Assembling his 'Tamoxifen Team'
It’s the Friday before Father’s Day, and V. Craig Jordan, Ph.D., who’s considered the “Father of Tamoxifen,” is sitting down to talk...
Analysis indicates blood cancer drugs are overpriced
The costs associated with cancer drug prices have risen dramatically over the past fifteen years, which concerns many top oncologists....
Breast-conserving therapy on the rise, but off-limits to...
The first national review of breast-conserving therapy (BCT) shows that over the last 13 years, rates of this treatment for...
Searching for an alternative to surgery for early lung...
Patients with operable stage I non-small cell lung cancer (NSCLC) could achieve better overall survival rates if treated with...
Benefits extended to same-sex married couples
The Supreme Court’s recent ruling on same-sex marriage has cleared the way for MD Anderson Cancer Center to offer some long-awaited...
Blood test could reveal pancreatic cancer earlier
MD Anderson researchers believe they may have found a way to detect pancreatic cancer at an early stage, before it has spread to other...
Sign of Epstein-Barr Virus found in chronic lymphocytic...
A molecule expressed by the Epstein-Barr virus is found in the B cells, bone marrow and plasma of patients with chronic lymphocytic...
MD Anderson collaborates on world’s first skull-scalp...
Doctors from MD Anderson and Houston Methodist Hospital have performed what is believed to be the world’s first partial skull and...
New chemo combo for advanced prostate cancer studied
Results of an MD Anderson clinical trial may change the perspective on a role for combination chemotherapy in advanced prostate cancer.
MD Anderson faculty members honored at ASCO's annual meeting
Two MD Anderson faculty members were awarded by the American Society for Clinical Oncology (ASCO) at the society’s annual meeting...
Risks seem to outweigh whole-brain radiation's rewards
Whole brain radiation to treat cancer that has spread to the brain is associated with significantly worse cognitive function than...
MD Anderson, Exact Sciences developing blood tests for lung...
MD Anderson and Madison, Wis.-based Exact Sciences Corp. have announced a partnership to co-develop and commercialize several...
MD Anderson receives $9 million in CPRIT funding
MD Anderson Cancer Center has received more than $9 million in research grants in the latest round of funding from the Cancer...
Fighting HPV by learning to talk about the disease
When asked why she’s so passionate about preventing the spread of HPV, Lois Ramondetta, M.D., is quick to answer.
“Cancers are...
A call to action in South Texas
Since its introduction in the 1940s, the Pap test has been successfully detecting abnormal cells in the cervix that, if left...
E-cigarettes' growing popularity underscores the need for...
In April, new federal data was released showing e-cigarette use has tripled among students in middle and high school. We asked MD...
Researchers work to control cancer’s evasive actions
New findings about regulation of PD-L1, a protein that allows cancer to evade the immune system, have shown therapeutic promise for...
A better understanding of a mutation's link to lung cancer
Mutations of the KRAS gene are commonly known to lead to cancer. But deeper understanding of exactly how they do this continues to be...
Beyond C-125: Detecting ovarian cancer earlier
Successful ovarian cancer treatment often relies on catching it early. A study at MD Anderson may help point to a new method of...
Harnessing a mushroom’s toxin to kill cancer
For some time, cancer scientists have considered alpha-amanitin, the toxin derived from “death cap” mushrooms, as a possible cancer...
Immunotherapy leader receives Pezcoller Foundation award
Cancer scientist James Allison, Ph.D., internationally known for his role in developing a new class of cancer immunotherapies, has...
MD Anderson researchers named to lung and ovarian cancer...
Approaches to cancer treatment developed by MD Anderson researchers as part of the institution’s Moon Shots Program will be, in part,...
Upon further review: Immunotherapy’s curative potential
Immunotherapy is complex, has curative potential for some patients when given alone or combined with other drugs, and needs further...
A chance to cut off cancer's fuel supply
Think of a waterfall, and you might see why cell-signaling pathways are important to cancer research. As water cascades, it impacts...
New hepatitis C drugs may strain the system
The cost of treating people infected with the hepatitis C virus (HCV) with newly approved therapies will likely place a tremendous...
Proton therapy offers more precision, fewer side effects...
The good news is death rates continue to decline for the most common types of cancer, including lung, colon, breast and...
A less-invasive route to uterine cancer diagnosis
In a study of women with high-grade uterine cancer, researchers at MD Anderson Cancer Center found sentinel lymph node (SLN) mapping...
Moon Shots Program puts antibody therapies in ORBIT
A new research platform of MD Anderson’s Moon Shots Program will lead a collaboration with an international pharmaceutical company to...
MD Anderson immunotherapy innovator wins Paul Ehrlich and...
James Allison, Ph.D., chair of Immunology at MD Anderson Cancer Center, was awarded the 2015 Paul Ehrlich and Ludwig Darmstaedter...
Inaugural awards benefit research, patient care in prostate...
Christopher Logothetis, M.D., chair and professor of Genitourinary Medical Oncology, is the recipient of the inaugural Finneran Family...
Research may show why some brain tumors resist treatment
Scientists at MD Anderson Cancer Center may have discovered why some brain cancer patients develop resistance to standard treatments...
Patrick Hwu is named head of Cancer Medicine
Patrick Hwu, M.D., chair of Melanoma Medical Oncology and Sarcoma Medical Oncology at MD Anderson Cancer Center, has been named...
New surgical protocol for ovarian cancer is showing...
Triathlete and marathoner Leslie Russell teaches reading to children with dyslexia in the Spring Branch Independent School District....
Developing a drug to starve cancer cells
The first experimental drug to be produced by MD Anderson’s drug discovery and development institute will kill cancer cells in a new...
MD Anderson receives $22.3 million in CPRIT research funding
It was announced last month that MD Anderson Cancer Center would be awarded more than $22 million in research grants from the Cancer...
Study: Lenvatinib improves survival for thyroid cancer...
In a pivotal Phase III study led by researchers at MD Anderson Cancer Center, the oral anti-angiogenic therapy lenvatinib has shown...
Targeting breast cancer by taking aim at cells that regulate blood...
Tumors require blood to emerge and spread. That is why MD Anderson Cancer Center scientists believe targeting blood vessel cells known...
Searching for how melanoma builds resistance to drugs
Powerful drugs known as BRAF-inhibitors have been crucial for melanoma patients, saving lives through their ability to turn off the...
MD Anderson researchers among Journal of Clinical Oncology’s...
Fourteen current and former MD Anderson researchers were represented in 11 of the 50 most-cited Journal of Clinical Oncology (JCO)...
Concurrent treatment of HIV and cancer improves survival outcomes
Concurrent HIV and cancer present special challenges in the clinic, regardless of which disease is diagnosed first. The simultaneous...
Former MD Anderson president Mendelsohn ‘Makes History’
John Mendelsohn, M.D., president of MD Anderson from 1996-2011, recently received the Texas State History Museum Foundation’s...
MD Anderson president elected to top cancer research academy
Ron DePinho, M.D., president of MD Anderson Cancer Center, will be inducted as a new fellow of the American Association for Cancer...
The mystery of what turns a protein to the dark side
Scottish author Robert Louis Stevenson tapped into primal fears when he penned “Dr. Jekyll and Mr. Hyde,” a 19th-century novel about a...
In the press, among peers, Melanoma Moon Shot communicates...
MD Anderson’s Moon Shots Program continues to keep the issue of indoor tanning — and its impact on teenagers — in the public...
Eight signs associated with impending cancer death are...
Researchers at MD Anderson have identified eight highly specific physical and cognitive signs associated with imminent death in cancer...
Understanding the architecture of disease
When skyscrapers go up, contractors rely on an infrastructure of steel beams and braces. Some cancers grow the same way, using a...
Collaboration should lead to better mining of clinical...
When cancer patients take part in a clinical trial to develop new therapies, they and their physicians want to know how they will feel...
Less surgery and better survival rates for patients with...
Thanks to the modern era of new chemotherapeutic and biologic agents available for managing their disease, patients with metastatic...
Working together to 'move the needle'
MD Anderson continues to rethink how industry and academia can collaborate in deeper and broader ways to develop new drugs and bring...
Joining with AstraZeneca to take on ovarian and gynecologic...
MD Anderson and AstraZeneca recently announced a multi-year strategic research collaboration to conduct multiple, parallel clinical...
MD Anderson receives top Chinese science and technology...
MD Anderson was presented the People’s Republic of China International Science and Technology Cooperation Award last month at a...
Shorter radiation course at higher doses may be beneficial
A shorter course of radiation therapy at higher doses per fraction than the standard regimen could reduce side effects and improve...
World Cancer Day and MD Anderson's daily mission
Feb. 4 is World Cancer Day, which was organized by the Union for International Cancer Control to raise awareness of the actions needed...
Combination therapy effective for higher-risk MDS/AML...
A phase two study investigating the potential of the drugs azacitidine (AZA) and lenalidomide (LEN), demonstrated that the two...
Antifibrotic agent showing benefits for advanced...
A study investigating the potential of the antifibrotic compound PRM-151 (PRM) for reducing progressive bone marrow fibrosis...
Efforts to improve treatments for melanoma of the eye
Although primary uveal melanoma can be effectively treated with radiation or surgery, patients with metastatic disease — or those at...
Health research: Pay now or pay later
By reducing investments in medical research, any short-term savings will prove to be very costly in the long run — and not just...
Targeting microRNA may benefit some ovarian and breast...
A genetic misfire called the 3q26.2 amplicon can cause real havoc. In fact, it’s among the most frequent chromosomal aberrations seen...
MD Anderson, Intrexon and ZIOPHARM connect on immunotherapy
Biotech companies Intrexon and ZIOPHARM Oncology have licensed unique MD Anderson immunotherapy technology, creating an...